Utilizing the most favorable cut-off point of the IGF2+ tumor cell score, participants in the TCGA dataset were classified into two distinct groups: those with a high ITRS and those with a low ITRS (ITRS referring to the IGF2+ tumor cells risk score). This evidence concerns the gene IGF2 and neoplasm.